BR112020013789A2 - métodos para o tratamento de afecções cutâneas inflamatórias - Google Patents

métodos para o tratamento de afecções cutâneas inflamatórias Download PDF

Info

Publication number
BR112020013789A2
BR112020013789A2 BR112020013789-8A BR112020013789A BR112020013789A2 BR 112020013789 A2 BR112020013789 A2 BR 112020013789A2 BR 112020013789 A BR112020013789 A BR 112020013789A BR 112020013789 A2 BR112020013789 A2 BR 112020013789A2
Authority
BR
Brazil
Prior art keywords
minocycline
composition
doxycycline
rosacea
administration
Prior art date
Application number
BR112020013789-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Swati KULKARNI
Bijay Kumar Padhi
Shavas Alikunju
Rajeev Singh Raghuvanshi
Srinivas Ramchandra SIDGIDDI
Anirudh GAUTAM
Original Assignee
Dr. Reddy's Laboratories Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65269058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112020013789(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dr. Reddy's Laboratories Ltd. filed Critical Dr. Reddy's Laboratories Ltd.
Publication of BR112020013789A2 publication Critical patent/BR112020013789A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112020013789-8A 2018-01-07 2019-01-07 métodos para o tratamento de afecções cutâneas inflamatórias BR112020013789A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201741023993 2018-01-07
IN201741023993 2018-01-07
PCT/IB2019/000144 WO2019135166A1 (en) 2018-01-07 2019-01-07 Minocycline for treating inflammatory skin conditions

Publications (1)

Publication Number Publication Date
BR112020013789A2 true BR112020013789A2 (pt) 2021-02-17

Family

ID=65269058

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020013789-8A BR112020013789A2 (pt) 2018-01-07 2019-01-07 métodos para o tratamento de afecções cutâneas inflamatórias

Country Status (11)

Country Link
US (4) US11191740B2 (https=)
EP (1) EP3735249A1 (https=)
JP (3) JP7561029B2 (https=)
KR (1) KR102705507B1 (https=)
CN (1) CN111818927A (https=)
AU (2) AU2019205134B9 (https=)
BR (1) BR112020013789A2 (https=)
CA (1) CA3087838A1 (https=)
EA (1) EA202091653A1 (https=)
MX (1) MX2020007222A (https=)
WO (1) WO2019135166A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111818927A (zh) 2018-01-07 2020-10-23 雷迪博士实验室有限公司 用于治疗炎性皮肤疾病的米诺环素
CA3106884C (en) 2018-07-19 2025-04-01 Doosan Bobcat North America, Inc. DISPLAY POSITION FOR CABIN WITH TILTING DOOR
CN120324439A (zh) * 2025-03-05 2025-07-18 福安药业集团宁波天衡制药有限公司 一种稳定的盐酸米诺环素胶囊及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
AU2002303250B2 (en) * 2001-04-05 2006-05-25 Collagenex Pharmaceuticals, Inc. Methods of treating acne
EP1494681A4 (en) 2002-04-16 2008-08-06 Collagenex Pharm Inc PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US20140186269A1 (en) 2013-01-03 2014-07-03 Foamix Ltd. Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
CN111818927A (zh) 2018-01-07 2020-10-23 雷迪博士实验室有限公司 用于治疗炎性皮肤疾病的米诺环素

Also Published As

Publication number Publication date
US11364212B2 (en) 2022-06-21
JP2024098011A (ja) 2024-07-19
CA3087838A1 (en) 2019-07-11
AU2019205134B9 (en) 2025-02-20
AU2019205134A1 (en) 2020-08-20
US20230131030A1 (en) 2023-04-27
EP3735249A1 (en) 2020-11-11
US20190209500A1 (en) 2019-07-11
US12594252B2 (en) 2026-04-07
KR20200108018A (ko) 2020-09-16
US20210121420A1 (en) 2021-04-29
AU2019205134A2 (en) 2020-08-20
WO2019135166A9 (en) 2020-07-16
JP7561029B2 (ja) 2024-10-03
JP2026031656A (ja) 2026-02-24
RU2020125984A3 (https=) 2022-02-07
US11191740B2 (en) 2021-12-07
US10905664B2 (en) 2021-02-02
US20200222345A1 (en) 2020-07-16
MX2020007222A (es) 2020-12-10
CN111818927A (zh) 2020-10-23
KR102705507B1 (ko) 2024-09-10
AU2019205134B2 (en) 2024-11-07
WO2019135166A1 (en) 2019-07-11
EA202091653A1 (ru) 2020-12-23
AU2025200826A1 (en) 2025-02-27
JP2021509409A (ja) 2021-03-25
RU2020125984A (ru) 2022-02-07

Similar Documents

Publication Publication Date Title
US12594252B2 (en) Methods for treating inflammatory skin conditions
KR20210147082A (ko) 디메틸푸마레이트를 포함하는 일일 저용량 투여용 약제학적 조성물
WO2009034541A2 (en) Controlled release pharmaceutical dosage forms of trimetazidine
BR112015026418B1 (pt) Formulação de liberação prolongada de colchicina e uso da referida formulação de liberação prolongada de colchicina
KR101156054B1 (ko) 안정한 에페리손 함유 서방성 의약조성물
BRPI0714937A2 (pt) forma de dosagem unitÁria oral, e, uso de uma forma de dosagem unitÁria
BRPI0708059A2 (pt) formulação de niacina de baixo rubor
JP6872135B2 (ja) 最適化高用量メサラジン含有錠剤
CA2416771C (en) 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid for treatment of cox-2 dependent disorders
CN114209667A (zh) 包含丙戊酸的延迟释放药物制剂和其用途
CN1248693C (zh) 复方氨基葡萄糖盐缓释制剂及其制备方法
RU2787528C2 (ru) Миноциклин для лечения воспалительных заболеваний кожи
AU2015326572A1 (en) A suspension
EA045615B1 (ru) Миноциклин для лечения воспалительных заболеваний кожи
WO2026096776A1 (en) Minocycline for use for the treatment of rosacea
HK40039196A (en) Minocycline for treating inflammatory skin conditions
TWI743059B (zh) 二氟甲基鳥氨酸及舒林酸（ｓｕｌｉｎｄａｃ），固定劑量組合調配物
BR102024020395A2 (pt) Combinação de celecoxibe - acetaminofeno de melhor estabilidade e procedimento para seu preparo
RU2690372C2 (ru) Лекарственные средства, содержащие диацереин, и способы снижения уровней мочевой кислоты в крови с его использованием
JP2021120397A (ja) 低１日用量で投与するためのフマル酸ジメチルを含む医薬組成物
BR112020005138A2 (pt) composição farmacêutica para tratamento da dor aguda e crônica, contendo polmacoxib e tramadol

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]